Clinical trials
Venous Thromboembolism (VTE) clinical trials
Below are recruiting venous thromboembolism (vte) clinical trials, each written for real people, not researchers. We’re tracking 61 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07288632Recruiting
Lung cancer gene test and blood clot risk study
This study looks at whether certain gene profiles in advanced lung cancer affect the risk of blood clots. It may help doctors better understand and prevent clots in people starting new cancer treatment.
Perugia, PerugiaAges 18 years+ - NCT07863115Recruiting
Preventing blood clots after leg injury with a cast
This study looks at a simple checklist to see who is at risk for blood clots after a leg injury that requires a cast or brace. It also checks how well people follow blood-thinning medication to prevent these clots.
MonastirAges 18 years+ - NCT07820670Recruiting
Blood thinner choice after cesarean section to prevent blood clots
This study compares two blood-thinner medicines given after a C-section to see which one works better at preventing dangerous blood clots. It may help women who are at higher risk for clots rest easier right after delivery.
HolonAges 18–50 - NCT07786779RecruitingPhase 1
Safety study of an injectable drug in healthy adults
This study tests a new injectable medication to see if it is safe and how the body processes it. It is looking for healthy adults to participate and will monitor for side effects and study how the drug works.
Beijing, Beijing MunicipalityAges 18–55 - NCT07654634Enrolling by invitation
Precision blood thinning therapy study
This trial tests personalized blood thinner treatment for people who need long-term anticoagulation for conditions like atrial fibrillation or blood clots. The goal is to find the safest and most effective dose for each patient.
Changsha, HunanAges 8 years+ - NCT07439991Recruiting
Study of blood clot risks after lung cancer surgery
This study looks at why some people develop blood clots after lung cancer surgery. By tracking your recovery for 30 days, researchers hope to find better ways to predict and prevent clots in the future.
Changchun, JilinAges 18 years+ - NCT06749223Recruiting
Testing a D-dimer blood test for blood clots
This study is testing a new D-dimer blood test (AQT90 FLEX) to see how well it detects blood clots in people who have symptoms but a low to moderate risk. If you join, this test may help rule out dangerous clots more quickly.
ViborgAges 18 years+ - NCT07143539Recruiting
Early exercise rehab after hospital stay for pulmonary embolism
This study tests if starting a supervised exercise program early after a hospital stay for a blood clot in the lungs (pulmonary embolism) helps patients recover better and feel less breathless. It is for people at higher risk of ongoing symptoms after their clot.
AarauAges 18 years+ - NCT07140211RecruitingPhase 3
Low-dose heparin to prevent blood clots after childbirth
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
BadenAges 18 years+ - NCT07015905RecruitingPhase 3
Study of REGN7508 vs. standard blood thinners after knee replacement
This trial compares a new blood thinner called REGN7508 to two standard blood thinners (apixaban and enoxaparin) to prevent blood clots after total knee replacement surgery. The goal is to see which is safer and more effective.
Sheffield, AlabamaAges 18 years+ - NCT07005024RecruitingPhase 3
Blood thinner dosing study for people with cancer starting treatment
This trial tests different ways to take the blood thinner apixaban to prevent blood clots in people with cancer who are starting or switching their cancer treatment. It aims to find the best dose for safety and effectiveness.
Burlington, VermontAges 18 years+ - NCT06937372Recruiting
Blood clot risk after hip fracture; trial comparing care approaches
This trial compares two approaches for preventing blood clots in older adults who broke a hip. The goal is to find the safest and most effective way to manage clot risk after surgery.
LondonAges 60–120 - NCT06731673Recruiting
HSP47 protein study in blood clots
This study looks at a protein called HSP47 in people with blood clots, heart attacks, or strokes caused by atrial fibrillation, compared to healthy volunteers. It aims to learn more about how blood clots form and may lead to better treatments.
Aarhus, Central RegionAges 18 years+ - NCT07464808Recruiting
Using a blood test to improve clot prevention in burn patients
This study tests if using a blood test called anti-factor Xa helps doctors give the right amount of blood-thinning medicine to prevent clots in burn patients. It's for adults with moderate-to-large burns who need clot prevention while in the intensive care unit.
Cairo, AbbassiaAges 21 years+ - NCT05089227RecruitingPhase 2
Long-term apixaban to prevent clots in autoimmune hemolytic anemia
This Phase 2 trial tests whether taking long-term apixaban (a blood thinner) can prevent venous blood clots in people with autoimmune hemolytic anemia (AIHA). It may help reduce the risk of dangerous clotting events if you meet safety and risk criteria.
DijonAges 18 years+ - NCT04295486RecruitingPhase 2
Low-dose aspirin to prevent blood clots after hip or knee surgery
This Phase 2 study tests the best dose of low-dose aspirin to help prevent dangerous blood clots after total hip or knee replacement surgery. If you’re at lower clot risk and can safely take aspirin, it may help reduce clot risk while you recover.
Miami, FloridaAges 19 years+ - NCT06494878RecruitingPhase 3
Aspirin after childbirth to prevent blood clots
This trial tests if taking aspirin after delivery helps prevent dangerous blood clots in women with certain risk factors. It's for new mothers who have a clotting disorder, were on bed rest, or have multiple other risk factors like high weight or preeclampsia.
BrusselsAges 18 years+ - NCT05756244Recruiting
Managing blood thinners during pregnancy to prevent clot problems
This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.
Durham, North CarolinaAges 18–60 - NCT07292376Enrolling by invitation
Preventing blood clots in cancer outpatients
This trial is testing a program to help prevent blood clots in people with cancer who are starting a new type of cancer treatment, like chemotherapy or targeted therapy. The goal is to see if better prevention strategies can keep you safe during treatment.
Burlington, VermontAges 18 years+ - NCT06939803Recruiting
AI tool to prevent blood clots in hospitalized patients
This trial tests an AI tool that helps doctors prevent blood clots in hospitalized patients. If you are admitted to a participating Vanderbilt hospital, you may be part of this study.
Nashville, TennesseeAges Any age - NCT06393764Recruiting
Blood clots in cancer patients: a long-term study
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
BrestAges 18–80 - NCT03041805Recruiting
Check whether a clot-risk score predicts recovery after vein surgery
This study looks at how well a clot-risk score (Caprini score) relates to blood clot checks and outcomes after varicose vein surgery. You may be asked to have an ultrasound scan a few weeks after your operation and be followed for about 4 weeks.
MoscowAges 18 years+ - NCT07196020Recruiting
Predicting blood clots during chemotherapy for certain cancers
This study looks at whether doctors can predict blood clots in people with certain cancers who are receiving chemotherapy. If you have ovarian, lung, stomach, or pancreatic cancer and are starting chemotherapy, you may be able to join and help improve clot prevention.
Cork, IrelandAges 18 years+ - NCT05920343RecruitingPhase 2/Phase 3
Preventing blood clots in genitourinary cancer with rivaroxaban
This trial tests whether rivaroxaban, a blood thinner pill, can help prevent dangerous blood clots in people with certain genitourinary cancers who are starting cancer treatment. It may lower clot risk, but it also has bleeding-risk tradeoffs that the study will monitor closely.
Ottawa, OntarioAges 18 years+
Hear when a new Venous Thromboembolism (VTE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for venous thromboembolism (vte)?
- Yes. Clin2 currently lists 61 recruiting venous thromboembolism (vte) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a venous thromboembolism (vte) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a venous thromboembolism (vte) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.